MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response-Reference-Cited by-同舟云学术

MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response

Published:2015-12-21 Issue:6 Volume:37 Page:7719-7727
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Besse Andrej,Sana Jiri,Lakomy Radek,Kren Leos,Fadrus Pavel,Smrcka Martin,Hermanova Marketa,Jancalek Radim,Reguli Stefan,Lipina Radim,Svoboda Marek,Slampa Pavel,Slaby Ondrej

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-4654-x.pdf

Reference30 articles.

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.

2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

3. Ahmed SU, Carruthers R, Gilmour L, Yildirim S, Watts C, Chalmers AJ. Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Res. 2015;75:4416–28.

4. Niyazi M, Siefert A, Schwarz SB, Ganswindt U, Kreth FW, Tonn JC, et al. Therapeutic options for recurrent malignant glioma. Radiother Oncol. 2011;98:1–14.

5. Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, et al. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. BMC Cancer. 2008;8:304.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic acid immunotherapeutics and vaccines: A promising approach to glioblastoma multiforme treatment;International Journal of Pharmaceutics;2023-05

2. Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration;Molecular Oncology;2023-02-18

3. Research progress on the role of Ndfip1 (Nedd4 family interacting protein 1) in immune cells;Allergologia et Immunopathologia;2023-01-01

4. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs;Expert Reviews in Molecular Medicine;2023

5. Unraveling the complexity: A comprehensive analysis of the PP2A in cancer and its potential for novel targeted therapies;Neoplasma;2023